One of the most important mechanisms of eukaryotic signalling is protein phosphorylation on tyrosine residues, which plays a pivotal role in development by regulating cell proliferation, differentiation and migration. Cellular phosphotyrosine (P.Tyr) levels are regulated by the antagonistic activities of the protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs). We have good insight into the function of PTKs at the molecular level and into the role of PTK-mediated signalling in development. Intuitively, PTPs and PTKs are equally important in development. Over the past decade, much emphasis has been placed on elucidation of the function of PTPs, which has led to good insights into the mechanism of PTP-mediated dephosphorylation. Although still relatively little is known about the role of PTPs in cell signalling and development, evidence is now emerging that several PTPs are crucial for proper development. Here I will introduce PTPmediated signalling and discuss recent ®ndings regarding the function of PTPs in development. q
Introduction
Protein phosphorylation on tyrosine residues is reversible. Protein-tyrosine kinases (PTKs) mediate phosphorylation of cellular proteins, and protein-tyrosine phosphatases (PTPs) dephosphorylation. Initially, PTPs were thought to be mere household-enzymes that were ubiquitously expressed and had low substrate speci®city. Following the puri®cation and sequencing of the ®rst PTP, PTPIB (Tonks et al., 1988a) , and subsequent identi®cation of CD45 as a transmembrane PTP Tonks et al., 1988b) , it became clear that the PTPs are a diverse family of enzymes with many members that have different substrate speci®city, are regulated differently, and are differentially expressed. By now, more than 75 PTPs have been cloned from many different species, ranging from bacteria to man. In fact, it has been estimated, based on random sequencing projects, that the human genome contains around 500 PTPs (Neel and Tonks, 1997) . Since the enzymatic counterparts of the PTPs, the PTKs, play an important role in development and since there is a wide variety of PTPs, it has been speculated that PTPs have an important function in development as well. By now, several PTPs have been shown to be crucial for proper embryonic development of invertebrates and vertebrates. These PTPs and their function will be described here.
crystal structures of the PTPs that have been solved to date demonstrates that the PTP domains are not only conserved in sequence, but also in structure (Denu et al., 1996; Fauman and Saper, 1996) . The sequences outside the catalytic domain are diverse and may regulate PTP activity and/or function in both the cytoplasmic and receptor PTPs.
Cytoplasmic protein-tyrosine phosphatases
Cytoplasmic PTPs contain a single catalytic PTP domain. Apart from the PTP domain, the cytoplasmic PTPs do not share sequence homology and the sequences outside the PTP domains have various functions (Mauro and Dixon, 1994) (Fig. 1) . For example, a hydrophobic region was identi®ed in PTP1B that directs PTP1B to the endoplasmic reticulum (ER) (Frangioni et al., 1992) . Activation of the protease calpain cleaves the catalytic domain off of the ERlocalization domain, releasing active PTP1B from the ER into the cytoplasm, where it may dephosphorylate target proteins (Frangioni et al., 1993) . Therefore, the hydrophobic region in PTP1B is involved in subcellular localization and may play a role in regulation of PTP1B activity. Drosophila DPTP61F contains a hydrophobic C-terminus, similar to PTP1B. In addition, an alternatively spliced form of DPTP61F was identi®ed with a nuclear localization signal that drives nuclear localization of DPTP61F. The catalytic activity of the two splice isoforms is indistinguishable, suggesting that the C-termini are involved in subcellular localization, rather than regulation of activity (McLaughlin and Dixon, 1993) .
Shp-1 and Shp-2 contain two Src Homology-2 (SH2) domains that bind speci®cally to P.Tyr in target proteins. These SH2 domains may thus be involved in substraterecognition (reviewed by Feng and Pawson, 1994; Van Vactor et al., 1998) . The recently solved crystal structure of Shp-2 demonstrates that unliganded Shp-2 is inactive, due to steric hindrance of the catalytic site by the N-terminal SH2 domain. Binding of P.Tyr-containing peptides or proteins induced a conformational change, thereby directly activating the PTP activity of Shp-2. Therefore, the N-terminal SH2 domain acts as a molecular switch, turning Shp-2 on or off, depending on the presence of P.Tyr-containing peptides (Hof et al., 1998) . Taken together, the SH2 domains in Shp-2 (and presumably also in Shp-1) have dual functions in regulating the catalytic activity of these PTPs, and in directing the PTP activity to target proteins.
Not only SH2 domains, but also other protein-protein interaction domains have been identi®ed in cytoplasmic PTPs that may direct these PTPs to speci®c subcellular locations. The band 4.1 domain in PTP-BL may mediate binding to cytoskeletal proteins, and the PDZ-domains binding to speci®c hydrophobic sequences in the C-termini of target proteins (Saras and Heldin, 1996) . The PEST-domains may mediate rapid degradation of PEST-containing PTPs, although the half-life of these PTPs reportedly is not extremely short (Charest et al., 1995) . Alternatively, the PEST sequences may provide proline rich binding sites for SH3 or WW domain containing proteins. For instance, PTP-PEST was found to associate with its substrate, p130
Cas , through a proline-rich sequence in PTP-PEST and the SH3 domain in p130
Cas (Garton et al., 1997) . In conclusion, the function of sequences outside the catalytic domain in cytoplasmic PTPs are three-fold: (1) regulation of activity, (2) subcellular localization, and (3) interaction with other proteins, including substrates.
Receptor protein-tyrosine phosphatases
The receptor PTPs have been classi®ed on the basis of structural differences, mainly in the extracellular domain, and at least six distinct types have been identi®ed (Fig.  2A) . The receptor PTPs contain one or two PTP domains, of which the membrane proximal domain (D1) contains the majority of the activity, while the membrane distal domain (D2) of several PTPs has been demonstrated to exhibit some PTP activity (Wang and Pallen, 1991; Wu et al., 1997) . However, some D2s lack residues that are essential for catalysis, including the catalytic site cysteine, and these D2s do not display any PTP activity (e.g. HPTPg, Krueger et al., 1990) . Nevertheless, D2s are highly conserved and mutation of only two residues in RPTPa D2 potentiates PTP activity to levels that are comparable to D1 (Lim et al., 1998; Buist et al., 1999) , suggesting that RPTP-D2s have an important function. However, in view of the low PTP activity of RPTP-D2s it is unlikely that this residual activity is physiologically relevant. Instead, RPTP-D2s may be involved in regulation of RPTP-D1 activity, in protein-protein interactions with other RPTPs (Wallace et al., 1998; Felberg and Johnson, 1998) , or with potential effector proteins (den Hertog et al., 1994; Serra-Page Ás et al., 1995) , or even in de®ning substrate speci®city by binding to substrates, thereby presenting them to catalytically active RPTP-D1s (Hunter, 1998) .
The extracellular domains of RPTPs are diverse, ranging (Brady-Kalnay et al., 1993; Gebbink et al., 1993; Sap et al., 1994) , which is mediated by the MAM domain and the immunoglobulin domain (Brady-Kalnay and Tonks, 1994; Zondag et al., 1995) . The extracellular domain of PTPb/z functions as a ligand for the neuronal receptor complexes Contactin/Caspr and Contactin/Nr-CAM and both soluble as well as membrane-bound RPTPb/z ectodomain induced neurite outgrowth of tectal neurons. The carbonic anhydrase domain and the FNIIIlike domain are required for binding to the Contactinprotein complexes (Peles et al., 1995; Sakurai et al., 1997) . Recently, the extracellular domain of a speci®c isoform of LAR was identi®ed as a receptor for the laminin/nidogen complex, and binding of laminin/nidogen to LAR may affect the actin cytoskeletal structure, resulting in morphological changes of cells (O'Grady et al., 1998) . However, even though cellular changes have been observed upon ligand binding to RPTPs, it remains to be determined whether intracellular PTP activity is affected by ligand binding. Whether and, if so, how RPTPs are regulated is an extremely important question that remains to be answered de®-nitively. In analogy to the receptor PTKs, RPTPs may be regulated by dimerization (Weiss and Schlessinger, 1998) . It has been demonstrated that chimeric Epidermal Growth Factor Receptor (EGFR)/CD45 is functionally inactivated by ligand-induced dimerization. CD45-D1 activity is essential for potentiation of T cell receptor (TCR) signalling, in that expression of CD45 in T cells that lack endogenous CD45 is suf®cient to restore otherwise defective TCR signalling (Desai et al., 1994) . Similarly, expression of chimeric EGFR/CD45 restored TCR signalling, but ligand-induced dimerization of EGFR/CD45 abolished restoration of TCR signalling, suggesting that CD45 activity is inhibited by dimerization (Desai et al., 1993) . Dimerization-induced inactivation of RPTPs is supported by structural evidence. RPTPa-D1 forms dimers in two independent crystals. These dimers are presumably inactive, since an amino-terminal helix-turn-helix wedge-like structure inserts into the catalytic site of a dyad-related monomer, thereby blocking the catalytic site (Bilwes et al., 1996) . The sequences that are involved in dimerization of RPTPa-D1 are conserved in other RPTPs, suggesting that RPTP-dimerization is a general phenomenon. Support for this model comes from binding studies in which CD45-D1 was found to form homodimers in solution (Felberg and Johnson, 1998) . Moreover, the wedge-like structure is essential for RPTPs-D1/RPTPd-D2 heterodimerization, in that deletion of the wedge in RPTPs-D1 abolished binding to RPTPd-D2 (Wallace et al., 1998) . In contrast, RPTPm-D1 did not form dimers in crystals, like RPTPa-D1 (Hoffmann et al., 1997). However, RPTPm has an unusually long juxtamembrane region, suggesting that either RPTPm is an exception that does not dimerize, or that the experimental conditions were not favouring RPTPm-D1 dimer formation in the crystals. Recent evidence strongly supports the hypothesis that RPTPs are inactivated by dimerization, since mutation of a single residue in the EGFR/CD45 chimaera, corresponding to a residue that is involved in dimerization in RPTPa-D1 crystals, abolished dimerization-induced inactivation (Majeti et al., 1998) . In conclusion, evidence is accumulating that dimerization negatively regulates RPTP activity. The model that dimerization inhibits RPTP activity is especially appealing because it is exactly the inverse of the enzymatic counterpart of RPTPs, the RPTKs, that are activated by dimerization. Whether ligand binding is required for RPTP dimerization, similar to the RPTKs, or whether ligands induce monomerization of otherwise dimeric RPTPs remains to be determined.
Function of PTPs in invertebrates
Genetic screens have provided detailed insight into the function of PTPs in lower eukaryotic systems. In yeast, much work has been done on PTPs that regulate MAPKs, and thus are involved in multiple signalling pathways (reviewed by Van Vactor et al., 1998) . In Dictyostelium discoidum, three PTPs have been identi®ed that have distinct effects on growth rate and development (Howard et al., 1992; Gamper et al., 1996) . Here, I will focus on the role of PTPs in development of multicellular organisms. Forward and reverse genetic screens using¯ies and worms have contributed tremendously to our insight into the role of PTPs in development. In fact, we are beginning to unravel the genetic pathways in which PTPs are involved, and biochemical evidence provides de®nitive proof for some of the genetic interactions. These analyses in invertebrates provide valuable insights into the function of PTPs, and it is tempting to extrapolate the genetic data obtained in¯ies and worms to vertebrates.
SH2-domain containing PTPs
One of the ®rst indications that PTPs play an important role in development came from the identi®cation of the gene that is responsible for the corkscrew phenotype in Drosophila as an SH2-domain containing PTP (Perkins et al., 1992) . Csw is most homologous to mammalian Shp-2, although Csw contains an insert in its catalytic domain. Csw is maternally required for normal determination of cell fates at the termini of the embryo and the csw mutant embryos are twisted or U-shaped and die during pupal stages (Perkins et al., 1992) . Analysis of double mutants indicated that csw is genetically downstream of the RPTK torso, and in parallel with D-Raf. Csw is not only required for Torso signalling, but also for signalling by other RPTKs, including Sevenless, Breathless and DER (Perkins et al., 1996; Allard et al., 1996) .
Csw may play a central role in RPTK to Ras signalling (Fig. 3) . Recent evidence suggests that Csw binds to Torso P.Tyr630 through its SH2 domain(s) and directly dephosphorylates Torso P.Y918, the binding site for RasGAP. In addition, Csw acts as an adaptor protein, coupling Torso to Ras activation via Drk and Sos. Therefore, Csw counteracts RasGAP in two ways, by prohibiting RasGAP activation and by counteracting RasGAP activity (Fig. 3) . The opposing activities of Csw and RasGAP modulate the strength of the Torso RPTK signal, thereby establishing the ®ne-tuning of Drosophila terminal development (Cleghon et al., 1998) . RasGAP is not the only downstream component in Csw-mediated signalling and other substrates are involved in the function of Csw as well. For instance, Dos is an adaptor protein that is genetically downstream of Csw in the Sevenless signalling pathway and Dos was identi®ed as a substrate of Csw, using a`substrate-trapping' procedure ( Fig. 3) Raabe et al., 1996) . In conclusion, Csw may be a regulator of RPTK to Ras signalling that acts at multiple sites.
The homolog of Shp-2 in C. elegans, PTP-2, is essential for proper oogenesis and although it is not essential for vulval development, mutation of PTP-2 affects vulval phenotypes caused by several other genes. Like in Drosophila, PTP-2 is genetically downstream of RPTKs, in paral- Fig. 3 . Csw may play a central role in RPTK to Ras signalling. Cswmediated dephosphorylation of the adaptor protein Dos leads to activation of Ras. In addition, Csw itself becomes phosphorylated on tyrosine upon binding to activated RPTKs, thereby providing binding sites for the SH3-SH2-SH3 adaptor protein Drk. Binding of Drk with its associated protein, Sos, a guanine nucleotide exchange factor for Ras, leads to activation of Ras. Moreover, binding of Csw to activated RPTKs may lead to dephosphorylation of speci®c binding sites in RPTKs. For instance, Csw dephosphorylates the binding site for the negative regulator of Ras, RasGAP, in the Torso RPTK, thereby prohibiting RasGAP activation. In conclusion, Csw is a modulator of RPTK signalling and is essential for several developmental processes in the Drosophila embryo, including eye development (mediated by the RPTK Sevenless), and speci®cation of embryonic terminal cells (mediated by the RPTK Torso). lel with or upstream of Ras (Gutch et al., 1998) , suggesting a similar role for C. elegans PTP-2 as for Drosophila Csw.
Receptor PTPs
The ®rst indication that RPTPs play an important role during development also came from work in Drosophila. The expression pattern of four RPTPs in Drosophila, DLAR, DPTP10D, DPTP99A and DPTP69D, with high and speci®c expression in motor neuron axons, suggested that these RPTPs are involved in axon guidance (Tian et al., 1991; Yang et al., 1991; Desai et al., 1996) . These three RPTPs belong to the type IIa and type III subfamilies of RPTPs, which are characterized by multiple immunoglobulin-like and FNIII-like domains (DLAR and DPTP69D), or only FNIII-like domains (DPTP99A and DPTP10D) in the extracellular domain (Fig. 2B) . Recently, genetic evidence con®rmed the importance of RPTPs in axon guidance, since Drosophila mutants were identi®ed with mutations in RPTPs that showed defects in axonal path®nding (Krueger et al., 1996; Desai et al., 1996; . The phenotype of these RPTP mutant embryos have been discussed in excellent recent reviews (Chien, 1996; Van Vactor et al., 1998; . Brie¯y, in DLAR mutant embryos, the segmental nerve b (SNb) axons bypass their normal muscle target region and continue to extend distally along the common pathway, following the intersegmental nerve (ISN) (Krueger et al., 1996) . DPTP69D mutant embryos show a complex axon path®nding phenotype, in that the SNb axon stops growing before reaching its target muscle, or it follows incorrect pathways and bypasses its target. DPTP99A mutants have no obvious axon path®nding phenotype. However, the function of DPTP69D and DPTP99A may be partially redundant, since the penetrance and the severity of the SNb defects in mutant embryos that lack both DPTP69D and DPTP99A is enhanced compared to DPTP69D mutant embryos (Desai et al., 1996) . Analysis of mutants that lack DLAR, DPTP69D and DPTP99A demonstrates that speci®c RPTPs are required for pathway decisions along the trajectories of the ISN and SNb motor nerves. In addition, only in the triple mutant the SNb axon does not progress beyond the ®rst branch point, indicating that any of the three RPTPs is suf®cient for progression beyond the ®rst branch point. It is noteworthy that these three RPTPs are only required for pathway decisions of particular axons, since the SN root branches (SNa and SNc) are relatively normal in embryos that lack all three RPTPs (Desai et al., 1997) .
Although it is clear that RPTPs play an important role in axon path®nding in Drosophila, the molecular mechanism underlying the involvement of these RPTPs remains to be determined. It has been demonstrated that the small GTP binding protein Rac is genetically downstream of DLAR (Kaufmann et al., 1998) . This interaction may be mediated by Trio, a large multi-domain protein that binds to human LAR and contains a Rac guanine nucleotide exchange factor domain (Debant et al., 1996) . It is noteworthy that C. elegans UNC-73, which is closely related to vertebrate Trio, speci®cally activates Rac and is required for proper cell and growth cone migration, presumably through regulation of cytoskeletal rearrangements (Steven et al., 1998) . Whether a Drosophila homolog of Trio couples DLAR to Rac remains to be determined, but this notion has led to a model for the involvement of DLAR in axon path®nding (Fig. 4 ). This linear model is far from complete, since other signalling proteins that interact with the cytoplasmic domain of LAR, including LIP-1 and Liprins (Serra-Page Ás et al., 1995; 1998) , may be involved in axon path®nding as well. Interestingly, recently the PTK Abl and its substrate Enabled (Ena) were found to play important roles in axon path®nding, which may be due to direct interactions with the DLAR pathway, since Abl and Ena associate with the cytoplasmic domain of DLAR, and are dephosphorylated by DLAR (Wills et al., 1999) . In view of the axon path®nding phenotype, it is highly likely that LAR ligands are involved in LAR-mediated axon path®nding. There is evidence that the extracellular domain of LAR is involved in path®nding in the leech, Hirudo medicinalis. HmLAR2, the leech homolog of DLAR, is speci®cally expressed on growth cones of transient neuron-like template cells, Comb cells, when these cell processes grow out rapidly. Injection of antibodies, directed at the extracellular domain of HmLAR2, leads to partial internalization of HmLAR2. Concomitantly, the processes of the HmLAR2-expressing cells project aberrantly and extend over shorter distances than normal, while the growth cones appear normal. These data suggest that the extracellular domain of HmLAR2 transduces extracellular signals that are required for normal growth cone path®nding (Gershon et al., 1998) .
The ®rst transmembrane PTP that was identi®ed in C. elegans is Clr-1, which contains two immunoglobulin-like and one FNIII-like domain (Fig. 2B ) (Kokel et al., 1998 Since catalytic activity of Clr-1 is required for its function, it is highly likely that Clr-1-mediated dephosphorylation acts as a negative regulator of egl-15 signalling (Kokel et al., 1998) .
The function of PTPs in vertebrates
Forward genetics experiments in invertebrates have provided insight into the function of several PTPs, as described above. Homologous PTPs have been identi®ed in vertebrates and it is tempting to speculate that these vertebrate PTPs have similar functions as their invertebrate counterparts. However, until now, such extrapolations have proved to be very dif®cult. In fact, still relatively little is known about the function of PTPs in vertebrate development, despite many extensive PTP expression studies, revealing complex spatio-temporal expression patterns. Many PTPs, in particular RPTPs, are highly and speci®cally expressed during brain development (reviewed by Stoker and Dutta, 1998) , suggesting that PTPs play an important role in neural development. Gene ablation studies have provided some insight into the function of PTPs in vertebrate development, although knock-outs of many PTPs disappointingly did not result in phenotypes, which is presumably due to redundancy. Double or triple knockouts of closely related subfamily members may be required to obtain insight into the function of these subfamilies of PTPs. Much work has been done, focussed at analysis of the function of PTPs in cell signalling, which has provided important clues as to the biological function of these PTPs. However, the most important question regarding PTP-signalling ± what are their substrates ± remains elusive in most cases. Here, I will discuss the (possible) role of several PTPs in vertebrate development.
SH2 domain-containing PTPs
In vertebrates, two SH2-containing PTPs have been identi®ed, Shp-1 and Shp-2. Shp-1 is predominantly expressed in haematopoietic cells, while Shp-2 is more broadly expressed. Shp-1 was identi®ed as the gene that is disrupted in the motheaten mutant mice (Shultz et al., 1993) . Two motheaten alleles have been identi®ed with varying severity, motheaten (me/me) and motheaten viable (me v /me v ). Me/me homozygous mice develop systemic autoimmune disease and die within 3±9 weeks after birth. The defects in these mice are linked to developmental or functional defects in the haematopoetic system (Shultz et al., 1993) , consistent with exclusive expression of Shp-1 in the haematopoetic system (Yi et al., 1992) . Shp-1 binds to speci®c P.Tyr residues in target proteins through its SH2 domains. Many potential Shp-1 substrates have been identi®ed, including haematopoietic receptors, e.g. the interleukin-3 (IL-3) receptor, associated kinases, e.g. ZAP-70, and adaptor proteins (reviewed by Frearson and Alexander, 1997) . However, which of these substrates are essential for the function of Shp-1 remains to be determined.
Gene targeting of Shp-2 in mice was done by deletion of exon 2 or exon 3 in two independent studies (Arrandale et al., 1996; Saxton et al., 1997) . Both groups report that targeting of Shp-2 led to embryonic lethality at day 10.5 and 8.5, respectively. Whether the exon 2 deletion is a null mutation remains to be determined, but as it turns out the exon 3 deletion gives rise to reduced (approximately 25% of wild type) expression of mutant Shp-2 with a deletion in the C-terminal SH2 domain. This mutant Shp-2 is not functional, since it does not bind to its normal targets (Saxton et al., 1997) . Targeting of Shp-2 exon 3 led to improper gastrulation and Shp-2 exon32/2 embryos died at mid-gestation with defects in the node, the notochord and in posterior elongation (Saxton et al., 1997) . Analysis of MAP kinase activation in ®broblasts, derived from the Shp-2 exon32/2 embryos, indicated that Shp-2 is essential for proper MAP kinase activation, since FGF-induced MAP kinase activation is transient in Shp-2 exon32/2 cells and sustained in wild type cells. Moreover, MAP kinase activation is differentially affected, since PDGF-induced MAP kinase activation is identical in Shp-2 exon32/2 and wild type ®broblasts (Saxton et al., 1997) . Conceivably, the function of Shp-2 in signalling of some RPTKs, including the FGFR, is essential for normal early vertebrate development. Overexpression of dominant negative Shp-2 caused severe posterior truncations in Xenopus embryos. In addition, in ectodermal explants, dominant negative Shp-2 blocked FGF-induced mesoderm induction and MAP kinase activation , again suggesting that Shp-2 acts as a positive component in FGFRsignalling. Taken together, all of the observed phenotypes, including the ones in invertebrates, are consistent with the large body of biochemical evidence that Shp-2 is required for proper RPTK signalling.
Other cytoplasmic PTPs
Relatively little is known about the role of the other cytoplasmic PTPs in vertebrate development. Several PTPs have been knocked out by gene targeting, or by gene trapping. For instance, a gene trap insertion in PTP-BL produced a fusion between PTP-BL and b-galactosidase, allowing detailed analysis of PTP-BL expression during development (Thomas et al., 1998) . PTP-BL is highly expressed in epithelial cells and in the peripheral nervous system, suggesting that PTP-BL plays an important role there. However, speci®c gene targeting by homologous recombination of PTP-BL did not induce obvious phenotypes in PTP-BL 2/2 mice, presumably due to redundancy (W. Hendriks, personal communication). Gene targeting of the T cell PTP, TC-PTP, which is highly expressed in haematopoietic cells led to speci®c defects in bone marrow, B cell lymphopoiesis and erythropoiesis, as well as in T and B cell functions. Deletion of TC-PTP is not embryonic lethal, but the TC-PTP 2/2 mice die 3±5 weeks after birth. The phenotype of the TC-PTP 2/2 mice demonstrates that TC-PTP plays an important role in both haemopoiesis and immune function (You-Ten et al., 1997) . Recently, PTP1B was knocked out and PTP1B 2/2 mice developed normally. However, PTP1B
2/2 mice displayed enhanced sensitivity to insulin and were resistant to weight gain, consistent with a role for PTP1B in insulin receptor dephosphorylation (Elchebly et al., 1999a) . Finally, PTP-PEST has been knocked out (Co Ãte Â et al., 1998) , which induces embryonic lethality around 8.5 days p.c. PTP-PEST 2/2 embryos display several abnormalities, from the central nervous system to the development of some cell lineages, derived from the endoderm (M. Tremblay, personal communication).
Interestingly, embryonic ®broblasts, derived from the PTP-PEST 2/2 embryos, facilitated identi®cation of p130
Cas , and p130 Cas -family members, Hef1 and Sin as substrates of PTP-PEST (Co Ãte Â et al., 1998) . In addition, the PTP-PEST 2/2 ®broblasts provided evidence that PTP-PEST is involved in the breakdown of focal adhesions (Augers-Loustau et al., 1999) , which may be why PTP-PEST is essential for early development. Taken together, we are beginning to get some insight into the role of PTPs in development, and since deletion of many cytoplasmic PTPs leads to embryonic lethality, it appears that these PTPs are essential for normal early development.
CD45
CD45 was the ®rst RPTP to be identi®ed, based on sequence homology to PTP1B in the intracellular domain (Tonks et al., 1988b; Charbonneau et al., 1988) . The extracellular domain contains one FNIII-like domain (Fig. 2) . Bona ®de CD45 ligands are not known, and therefore it is not clear whether the CD45 ectodomain acts as a ligand binding domain. Many splice isoforms of CD45 have been identi®ed, all of which are expressed exclusively in the haematopoietic system. Gene targeting of exon 6 was aimed at deletion of a speci®c isoform of CD45, but instead abolished expression of all CD45 isoforms in B cells and most T cells (Kishihara et al., 1993) . T cell development was severely affected in CD45 exon62/2 mice, while development of B cells appeared normal (Kishihara et al., 1993) . However, signi®cant defects in B cell maturation and signalling have been identi®ed (Cyster et al., 1996) . CD45-null mice were generated by targeting of the invariant exon 9, and here T cell development was disrupted even more severely at the CD4 2 CD8 2 to CD4 1 CD8 1 transition and later when CD4 1 CD8 1 cells develop into CD4 1 or CD8 1 thymocytes (Byth et al., 1996) . CD45 potentiates T cell receptor (TCR) and B cell receptor (BCR) activation and over the past decade much emphasis has been placed on elucidation of the mechanism by which CD45 is involved in TCR and BCR potentiation, leading to detailed insight into the process (Fig. 5 ) (reviewed by Frearson and Alexander, 1997) . CD45 dephosphorylates the inhibitory C-terminal phosphorylation site in Lck and Fyn, thereby activating these Src-family PTKs (Mustelin et al., 1989; Ostergaard et al., 1989; Shiroo et al., 1992) . Upon ligation of the TCR, activated Lck and possibly also Fyn phosphorylate components of the TCR, including CD3-1 and TCR-z on Immunoreceptor Tyrosine-based Activation Motifs (ITAMs). Phosphorylated ITAMs provide binding sites for SH2-containing signalling molecules, including the PTK, ZAP-70, leading to subsequent intracellular signalling (reviewed by Qian and Weiss, 1997) . In thymocytes that lack CD45, Lck and Fyn are not activated and engagement of the TCR does not induce tyrosine phosphorylation of the TCR, nor any of the downstream events, demonstrating that CD45 is essential for TCR signalling. Although it has not been proven formally, it is tempting to speculate that CD45-mediated potentiation of the TCR is involved in T cell development.
LAR subfamily
The mammalian LAR subfamily consists of three members, LAR, RPTPd and RPTPs. Due to alternative splicing, many different isoforms exist of these three RPTPs that may have different functions (Pulido et al., 1995) . During mouse development, these three RPTPs are differentially expressed. LAR is highly expressed in the basal lamina-associated epithelial tissues of (neuro)ectodermal, neural crest/ectomesenchyme and endodermal origin. RPTPd and RPTPs expression largely overlap with high expression in (neuro)ectodermal, neural crest-and mesodermal-derived tissues (Schaapveld et al., 1998) . Since RPTPd and RPTPs are highly expressed in the developing nervous system, these RPTPs may be the homologs of DLAR, rather than mammalian LAR itself. Further evidence, supporting this hypothesis is that gene targeting of LAR, using a gene trap approach did not induce an obvious neuronal phenotype (Skarnes et al., 1995) . Close examination of mice with a gene trap insertion in the LAR gene, in which expression of full length LAR is greatly reduced, indicated that the size of cholinergic neurons was signi®cantly reduced and that cholinergic innervation of the dentate gyrus was markedly decreased (Yeo et al., 1997) . Schaapveld et al. (1997) generated mice lacking the sequences encoding both LAR PTP domains by gene targeting. LAR PTP2/2 mice are viable and do not display an obvious neuronal phenotype. In fact, these mice develop normally, without obvious histological abnormalities. However, LAR PTP2/2 females have mammary gland defects during gestation, due to impaired terminal differentiation of alveoli at late pregnancy, resulting in defective milk production (Schaapveld et al., 1997) . From these LAR PTP2/2 mice it is clear that LAR PTP activity is not essential for proper development of the mammalian nervous system (Schaapveld et al., 1997) . However, RPTPd and RPTPs may take over LAR's function in LAR 2/2 mice. RPTPd 2/2 mice are viable and appear to display growth retardation, early mortality, abnormal posture and dramatic motor defects (Uetani et al., 1997) , while RPTPs 2/2 mice display pituitary dysplasia, defects in the olfactory lobes and a reduction in the total central nervous system size and cell number (Elchebly et al., 1999b; Wallace et al., 1999) . It is likely that the highly homologous LAR family members have redundant functions. In fact, all three family members associate with LAR-interacting proteins, including LIP-1 (Pulido et al., 1995) , and Liprins (Serra-Page Ás et al., 1998), suggesting that indeed downstream signalling is similar. In order to obtain insight into the function of the LAR subfamily, double or even triple knock-out mice will have to be generated.
MAM-domain containing RPTPs
The MAM-domain containing RPTPs, RPTPm, RPTPk and PCP2 are differentially expressed during vertebrate development with distinct and complementary expression patterns, suggesting that these RPTPs play a role in organogenesis and in tissue formation (Fuchs et al., 1998) . However, functional inactivation of RPTPk (Skarnes et al., 1995) and gene targeting of RPTPm (M.F.B.G. Gebbink, personal communication) did not induce obvious phenotypes. Perhaps the phenotypes are subtle and much work is needed to elucidate the in vivo function of these RPTPs. Alternatively, redundancy may be responsible for the lack of phenotypes, although this is unlikely since the type IIb RPTPs are not co-expressed in the same cells (Fuchs et al., 1998) .
Cell biological experiments indicated that the extracellular domains of RPTPm and RPTPk engage in homophilic interactions, suggesting that RPTPm and RPTPk are involved in cell-cell interactions (Brady-Kalnay et al., 1993; Gebbink et al., 1993; Sap et al., 1994) . In addition, further evidence suggests that the MAM-subfamily of RPTPs interacts with cadherins and catenins. For instance, RPTPk binds to b-catenin and plakoglobin (g-catenin) in vivo and in vitro, and b-catenin may be a substrate of RPTPk (Fuchs et al., 1996) . Initially, such an interaction between a RPTP and the cadherin-catenin complex was demonstrated for the archetypical MAM-domain containing PTP, RPTPm (Brady-Kalnay et al., 1995) . The interaction between RPTPm and cadherins has been the subject of debate (Zondag et al., 1996) , but recent evidence strongly suggests that RPTPm interacts with cadherins (BradyKalnay et al., 1998) . Whether RPTPm is involved in dephosphorylation of the cadherin-catenin complex remains to be determined. Although the function of the MAM-domain containing RPTPs in development remains elusive at the moment, it is highly likely that this subfamily of RPTPs plays a role in cell-cell interactions, which may be mediated by the interaction with the cadherin-catenin complex.
RPTPa
The RPTPa-RPTP1 subfamily of RPTPs is characterized by a very short extracellular domain. RPTP1 has the shortest extracellular domain (27 residues), while RPTPa (123 residues) is the best characterized of the two. RPTPa mRNA and protein are highly expressed in mouse dorsal root ganglia and cranial sensory ganglia. In addition, RPTPa expression is enhanced in the adrenal gland, indicating that RPTPa is highly expressed in derivatives of the neural crest (den Hertog et al., 1996) . During chicken development, RPTPa mRNA expression is enhanced in pre-migratory and migrating granule cells, as well as in Bergmann glia and their radial processes (Fang et al., 1996) . A detailed analysis of RPTPa expression in the retinotectal system of the chick indicates that RPTPa expression is restricted to Muller glia cells and radial glia of the retina and of the tectum (Ledig et al., 1999) . These expression data suggest that RPTPa has a function in derivatives of the neural crest and/or in glia cells.
Gene targeting of RPTPa did not result in obvious developmental defects (J. Sap, personal communication) . RPTP1 knock-out mice do not have an obvious developmental phenotype, although they may display subtle physiological defects (A. Elson, personal communication). The lack of obvious developmental phenotypes in RPTPa and RPTP1 knock-out mice suggests that the function of these RPTPs is taken over by related RPTPs (possibly by each other) or that the phenotypes are rather subtle. A double knock-out with a deletion of both RPTPa and RPTP1 may provide insight into the role of this subfamily of RPTPs in development.
One of the ®rst indications that RPTPa is involved in developmental processes, came from in vitro studies using pluripotent P19 embryonal carcinoma cells. During neuronal differentiation of P19 cells, RPTPa expression is transiently induced with highest levels of expression preceding the neuronal phenotype. Overexpression of RPTPa altered the differentiation fate of P19 EC cells, in that retinoic acid induced neuronal differentiation instead of endodermal and mesodermal differentiation. Neuronally differentiated RPTPa-expressing P19 cells formed bona ®de terminally differentiated neurons, illustrated by their electrical excitability (den Hertog et al., 1993) .
The mechanism by which RPTPa is involved in neuronal differentiation remains to be determined. The PTK Src may be a component of the RPTPa-signalling pathway. Src is negatively regulated by Csk-mediated tyrosine phosphorylation in its C-terminus (at position 527) (Nada et al., 1991) . Overexpression of RPTPa leads to dephosphorylation and thus activation of Src in Rat Embryo Fibroblasts (REFs) and P19 EC cells (Zheng et al., 1992; den Hertog et al., 1993) . In addition, RPTPa dephosphorylates Src P.Tyr527 in vitro, suggesting that the effect observed in REFs and in P19 cells is direct (den Hertog et al., 1993) . Moreover, Src activity is reduced in RPTPa 2/2 embryonic ®broblasts, strongly suggesting that Src is a substrate of RPTPa (Ponniah et al., 1999; Su et al., 1999) .
The adaptor protein GRB2 has been identi®ed to bind to tyrosine phosphorylated RPTPa in vivo and in vitro, and thus may act as an effector protein of RPTPa (den Hertog et al., 1994; Su et al., 1994) . However, GRB2-binding appears not to be involved in the RPTPa-induced phenotype in P19 cells, since mutant RPTPa-Y789F that does not bind GRB2 still alters the differentiation fate of P19 cells in favour of neuronal differentiation (J. den Hertog, unpublished data) . Not only the GRB2 SH2 domain, but also the C-terminal SH3 domain is involved in binding to RPTPa (den Hertog and Hunter, 1996; Su et al., 1996) . The region in RPTPa that is involved in binding of the SH3 domain suggests that GRB2 may be involved in negative regulation of RPTPa activity, since the C-terminal SH3 domain presumably blocks access to the catalytic site of RPTPa-D1. Future work will provide insight into the role of GRB2-binding in the function of RPTPa.
Conclusion
Much progress has been made over the past couple of years in elucidation of the function of PTPs in development. However, the function of many PTPs still remains elusive. From the functional analyses that have been done with PTPs to date, using mutant¯ies and worms, and using knock-out mice, a common theme is emerging that cytoplasmic PTPs play a role early during development with severe defects upon inactivation of these genes, while the RPTPs have a more subtle function later during development, which is redundant in most cases as well. As a result, especially the function of the RPTPs in vertebrate development is unclear at the moment and insight may require generation of mice with multiple targeted RPTP genes, knocking out whole subfamilies of RPTPs.
